Nearly Three-Quarters of Consumers in Anthem, Inc.-Affiliated 2022 Medicare Advantage Plans Will Be Enrolled in Plans That Are Highly Rated by CMS
October 08 2021 - 1:29PM
Business Wire
Results show impact of Anthem’s investments in
its subsidiaries to improve consumer experience and clinical
outcomes
Anthem, Inc. (NYSE: ANTM) announced today that, heading into
2022, more than 72 percent of Medicare Advantage consumers enrolled
in Anthem’s affiliated health plans will be in plans rated four
stars or better. This year’s ratings reflect Anthem’s long-term
investments in enhancing consumers’ healthcare experience;
collaborating with providers focused on delivering affordable,
high-quality care; and increasing access to products and services
that address consumers’ whole health.
“This increase in the percentage of members enrolled in highly
rated plans is a result of our continued commitment to providing
Medicare consumers access to high-quality, affordable healthcare
services and experiences that meet their unique needs and help them
improve their health and wellbeing,” said Felicia Norwood,
Executive Vice President and President, Government Business
Division, Anthem, Inc. “We will continue to create innovative
products and services and forge collaborations in and outside of
the industry to further increase the percentage of our consumers in
highly rated Medicare Advantage plans in the future.”
Medicare Star Ratings are issued by the Centers for Medicare
& Medicaid Services (CMS), and rate health plans on a scale of
1-5 Stars (5 Stars = Excellent). Star Ratings are derived as a
composite of dozens of measures that gauge areas such as health
plan members’ rating of service and care, how well provider
partners detect illness and keep members healthy, and how well
plans help members use recommended and safe prescription
medications.
During 2020, the measurement year on which these 2022 CMS
ratings are based, COVID-19 presented Medicare consumers with
significant challenges in accessing care as well as achieving and
maintaining good health. Anthem-affiliated Medicare health plans
quickly adjusted to this unique situation and provided consumers
access to healthcare in different ways, including virtual care
options. The health plans also reached out to members at higher
risk for situations like food insecurity and loneliness to support
them with additional services during those difficult times.
Anthem will continue to invest in its digital-first strategy,
which will help consumers receive healthcare services where, when,
and how they want them. Anthem’s affiliated Medicare plans are also
committed to taking a whole-health approach in developing their
product portfolios, which includes increasing access to services
that address social drivers of health that significantly contribute
to an individual’s health and improved quality of life.
For 2022, two Anthem-affiliated health plans will be rated five
stars by CMS’ Medicare Star Ratings program. HealthSun Health Plans
in Florida will achieve a five-star rating, for the fifth year in a
row (2018, 2019, 2020, 2021, and 2022). Optimum Healthcare, also in
Florida, will be rated five stars for 2022, an improvement from
last year.
The annual Medicare Star Ratings are posted online at
www.medicare.gov.
Every year, Medicare evaluates plans based on a 5-star rating
system. Anthem, Inc.'s affiliated health plans are Medicare
Advantage Organizations and Prescription Drug Plans with Medicare
contracts. Enrollment in Anthem-affiliated health plans depends on
contract renewal.
About Anthem, Inc.
Anthem is a leading health benefits company dedicated to
improving lives and communities, and making healthcare simpler.
Through its affiliated companies, Anthem serves more than 117
million people, including more than 44 million within its family of
health plans. We aim to be the most innovative, valuable and
inclusive partner. For more information, please visit
www.antheminc.com or follow @AnthemInc on Twitter.
Forward-Looking Statements
This document contains certain forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. Forward-looking statements reflect our views about future
events and financial performance and are generally not historical
facts. Words such as “expect,” “feel,” “believe,” “will,” “may,”
“should,” “anticipate,” “intend,” “estimate,” “project,”
“forecast,” “plan” and similar expressions are intended to identify
forward-looking statements. These statements include, but are not
limited to: financial projections and estimates and their
underlying assumptions; statements regarding plans, objectives and
expectations with respect to future operations, products and
services; and statements regarding future performance. Such
statements are subject to certain risks and uncertainties, many of
which are difficult to predict and generally beyond our control,
that could cause actual results to differ materially from those
expressed in, or implied or projected by, the forward-looking
statements. You are cautioned not to place undue reliance on these
forward- looking statements that speak only as of the date hereof.
You are also urged to carefully review and consider the various
risks and other disclosures discussed in our reports filed with the
U.S. Securities and Exchange Commission from time to time, which
attempt to advise interested parties of the factors that affect our
business. Except to the extent otherwise required by federal
securities laws, we do not undertake any obligation to republish
revised forward-looking statements to reflect events or
circumstances after the date hereof. These risks and uncertainties
include, but are not limited to: the impact of large scale medical
emergencies, such as public health epidemics and pandemics,
including COVID-19, and catastrophes; trends in healthcare costs
and utilization rates; our ability to secure sufficient premium
rates, including regulatory approval for and implementation of such
rates; the impact of federal and state regulation, including
ongoing changes in the Patient Protection and Affordable Care Act
and the Health Care and Education Reconciliation Act of 2010, as
amended; changes in economic and market conditions, as well as
regulations that may negatively affect our liquidity and investment
portfolios; our ability to contract with providers on
cost-effective and competitive terms; competitive pressures and our
ability to adapt to changes in the industry and develop and
implement strategic growth opportunities; reduced enrollment;
unauthorized disclosure of member or employee sensitive or
confidential information, including the impact and outcome of any
investigations, inquiries, claims and litigation related thereto;
risks and uncertainties regarding Medicare and Medicaid programs,
including those related to non-compliance with the complex
regulations imposed thereon; our ability to maintain and achieve
improvement in Centers for Medicare and Medicaid Services Star
ratings and other quality scores and funding risks with respect to
revenue received from participation therein; a negative change in
our healthcare product mix; costs and other liabilities associated
with litigation, government investigations, audits or reviews;
risks and uncertainties related to our pharmacy benefit management
(“PBM”), business including non-compliance by any party with the
PBM services agreement between us and CaremarkPCS Health, L.L.C.;
medical malpractice or professional liability claims or other risks
related to healthcare and PBM services provided by our
subsidiaries; general risks associated with mergers, acquisitions,
joint ventures and strategic alliances; changes in U.S. tax laws;
possible impairment of the value of our intangible assets if future
results do not adequately support goodwill and other intangible
assets; possible restrictions in the payment of dividends from our
subsidiaries and increases in required minimum levels of capital;
our ability to repurchase shares of our common stock and pay
dividends on our common stock due to the adequacy of our cash flow
and earnings and other considerations; the potential negative
effect from our substantial amount of outstanding indebtedness; a
downgrade in our financial strength ratings; the effects of any
negative publicity related to the health benefits industry in
general or us in particular; failure to effectively maintain and
modernize our information systems; events that may negatively
affect our licenses with the Blue Cross and Blue Shield
Association; the impact of international laws and regulations;
intense competition to attract and retain employees; and various
laws and provisions in our governing documents that may prevent or
discourage takeovers and business combinations.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211008005491/en/
Media Relations: Hieu Nguyen hieu.nguyen2@anthem.com
Anthem (NYSE:ANTM)
Historical Stock Chart
From May 2024 to Jun 2024
Anthem (NYSE:ANTM)
Historical Stock Chart
From Jun 2023 to Jun 2024